Decision Management Int'l

Decision Management International (“DMI”) is a global software and professional services provider focused on serving FDA regulated industries. To date, DMI has successfully completed over 300 projects for approximately 100 facilities of client companies, which include many of the leading companies in the pharmaceutical, biotechnology and medical device industries. DMI provides customers with integrated, efficient and cost effective software and consulting solutions used in the manufacture of FDA regulated products. DMI’s proprietary software solutions and consulting services benefit customers in many ways, including reducing process complexity and paperwork, streamlining documentation and approval processes, improving manufacturing yields and efficiencies, reducing errors, enhancing regulatory compliance, shortening product development cycles, reducing the probability of costly product recalls, and reducing production costs.

has sold $14M Series A Convertible Preferred Stock to

The undersigned acted as the exclusive placement agent to Decision Management Int'l for this private equity transaction.

Back to Transactions

Client Testimonials

"Hyde Park’s team guided us through the process, providing us with a number of high quality counter-parties, and supported us through the transaction structuring, negotiation and due diligence. We are very pleased with the outcome and excited for the future of DTS.”
Allen Ibaugh, Co-Founder and CEO of Data Transfer Solutions
“We enjoyed working with Hyde Park Capital and appreciated their M&A expertise in the technology services sector and their help on this important transaction.”
Chris Toepke, CEO of Trifecta
“We very much appreciated the assistance of Hyde Park Capital on this strategic acquisition for ITE. Their M&A experience was quite helpful to our team and the overall process and assured the deal was well executed and we got it closed on schedule.”
Scott Dols, CEO of Industrial Truck & Equipment, LLC